These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 12036725)

  • 21. Antibacterial activity of anesthetic solutions and preservatives: an in vitro comparative study.
    Dantas PE; Uesugui E; Nishiwaki-Dantas MC; Mimica LJ
    Cornea; 2000 May; 19(3):353-4. PubMed ID: 10832698
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A new lipid emulsion formulation with high antimicrobial efficacy using chitosan.
    Jumaa M; Furkert FH; Müller BW
    Eur J Pharm Biopharm; 2002 Jan; 53(1):115-23. PubMed ID: 11777759
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Enhancement of the antimicrobial properties of bacteriophage-K via stabilization using oil-in-water nano-emulsions.
    Esteban PP; Alves DR; Enright MC; Bean JE; Gaudion A; Jenkins AT; Young AE; Arnot TC
    Biotechnol Prog; 2014; 30(4):932-44. PubMed ID: 24616404
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bactericidal activity of 0.5% bupivacaine with preservatives on microorganisms in the human skin flora.
    Sakuragi T; Ishino H; Dan K
    Reg Anesth; 1997; 22(2):178-84. PubMed ID: 9089861
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Submicron emulsions as drug carriers. Studies on destabilization potential of various drugs.
    Sznitowska M; Janicki S; Dabrowska E; Zurowska-Pryczkowska K
    Eur J Pharm Sci; 2001 Jan; 12(3):175-9. PubMed ID: 11113636
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Stability of fortified cefazolin ophthalmic solutions prepared in artificial tears containing surfactant-based versus oxidant-based preservatives.
    Rojanarata T; Tankul J; Woranaipinich C; Potawanich P; Plianwong S; Sakulma S; Saehuan C
    J Ocul Pharmacol Ther; 2010 Oct; 26(5):485-90. PubMed ID: 20879806
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lyophilized Cheliensisin A submicron emulsion for intravenous injection: characterization, in vitro and in vivo antitumor effect.
    Zhao D; Gong T; Fu Y; Nie Y; He LL; Liu J; Zhang ZR
    Int J Pharm; 2008 Jun; 357(1-2):139-47. PubMed ID: 18329194
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lipophilic Arginine Esters: The Gateway to Preservatives without Side Effects.
    Shahzadi I; Jalil A; Asim MH; Hupfauf A; Gust R; Nelles PA; Knabl L; Bernkop-Schnürch A
    Mol Pharm; 2020 Aug; 17(8):3129-3139. PubMed ID: 32598849
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Compatibility of a commercially available low-density polyethylene eye-drop container with antimicrobial preservatives and potassium ascorbate.
    Barnes AR
    J Clin Pharm Ther; 1995 Dec; 20(6):341-4. PubMed ID: 8847373
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Nisin, a potential preservative for topical preparations].
    Valenta C; Bernkop-Schnürch A; Teltscher C
    Pharmazie; 1996 Feb; 51(2):119-22. PubMed ID: 8720808
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The physical stability of thermally-stressed phospholipid-based emulsions containing methyl, propyl and heptyl parabens as model drugs.
    Zhang X; Kirsch LE
    Int J Pharm; 2003 Oct; 265(1-2):133-40. PubMed ID: 14522126
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Development of a multidose formulation for a humanized monoclonal antibody using experimental design techniques.
    Gupta S; Kaisheva E
    AAPS PharmSci; 2003; 5(2):E8. PubMed ID: 12866935
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Preparation and characterization of a submicron lipid emulsion of docetaxel: submicron lipid emulsion of docetaxel.
    Gao K; Sun J; Liu K; Liu X; He Z
    Drug Dev Ind Pharm; 2008 Nov; 34(11):1227-37. PubMed ID: 18720137
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Solid lipid nanoparticles as effective reservoir systems for long-term preservation of multidose formulations.
    Cerreto F; Paolicelli P; Cesa S; Abu Amara HM; D'Auria FD; Simonetti G; Casadei MA
    AAPS PharmSciTech; 2013 Jun; 14(2):847-53. PubMed ID: 23625652
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Seven-day viable analysis of some ophthalmic preparations with different concentrations of benzalkonium chloride.
    Adil H; Sheikh D; Ahmed I; Sheikh MR; Ali G
    Pak J Pharm Sci; 1995 Jul; 8(2):1-10. PubMed ID: 16420997
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Physical properties of parabens and their mixtures: solubility in water, thermal behavior, and crystal structures.
    Giordano F; Bettini R; Donini C; Gazzaniga A; Caira MR; Zhang GG; Grant DJ
    J Pharm Sci; 1999 Nov; 88(11):1210-6. PubMed ID: 10564071
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ionic liquids as ingredients in topical drug delivery systems.
    Dobler D; Schmidts T; Klingenhöfer I; Runkel F
    Int J Pharm; 2013 Jan; 441(1-2):620-7. PubMed ID: 23123180
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Influence of droplet size on the efficacy of oil-in-water emulsions loaded with phenolic antimicrobials.
    Terjung N; Löffler M; Gibis M; Hinrichs J; Weiss J
    Food Funct; 2012 Mar; 3(3):290-301. PubMed ID: 22183117
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association of nicotinamide with parabens: effect on solubility, partition and transdermal permeation.
    Nicoli S; Zani F; Bilzi S; Bettini R; Santi P
    Eur J Pharm Biopharm; 2008 Jun; 69(2):613-21. PubMed ID: 18207718
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Release of antiseptics from the aqueous compartments of a w/o/w multiple emulsion.
    Tedajo GM; Bouttier S; Fourniat J; Grossiord JL; Marty JP; Seiller M
    Int J Pharm; 2005 Jan; 288(1):63-72. PubMed ID: 15607258
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.